7.2.1 Topical HRT for vaginal atrophy
    
											  
                        
                            | Choice | Drug | 
|---|
| 1st choice | Estriol 0.1% intravaginal cream | 
| 2nd choice | Estradiol 10microgram vaginal tablets | 
|  |  | 
Prescribing Notes
- Prescribe as per NICE NG23.
- Offer vaginal oestrogen to women with urogenital atrophy (including those on systemic HRT) and continue treatment for as long as needed to relieve symptoms.
- Consider patient preference and response when selecting the formulation of vaginal oestrogen e.g. cream or vaginal tablets.
- For people with a personal history of breast cancer see NICE NG23.
- Women using long-term vaginal oestrogen treatments do not need to add in cyclical progestogen.
- For systemic HRT options see 6.4.1